Kepos Capital’s Stryve Foods, Inc. Class A Common Stock SNAX Stock Holding History

Kepos Capital’s Portfolio SNAX Stock Details SNAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,967	Closed	-$158K	–	685
2021 Q3	$158K	Buy	+1,967	New	+$224K	0.01%	492

Other funds holding SNAX

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

Altium Capital Management New York $42M AUM

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

Kepos Capital's SNAX Position: Q4 2021 in Review

Kepos Capital sold out of Stryve Foods, Inc. Class A Common Stock (SNAX) in Q4 2021, closing a stake of 1,967 shares — an estimated $158K sold.

Kepos Capital first reported a position in SNAX in Q3 2021 and held it in 1 quarter. The position peaked at $158K in Q3 2021. 23 funds tracked by Wall St. Rank hold SNAX as of Q4 2021.

Kepos Capital reported no remaining Stryve Foods, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
Kepos Capital sold 1,967 Stryve Foods, Inc. Class A Common Stock shares in Q4 2021, an estimated $158K.
Kepos Capital first reported a position in Stryve Foods, Inc. Class A Common Stock in Q3 2021 and held it in 1 quarter.
Kepos Capital's Stryve Foods, Inc. Class A Common Stock position peaked at $158K in Q3 2021.
23 funds tracked by Wall St. Rank held Stryve Foods, Inc. Class A Common Stock as of Q4 2021.

Based on Kepos Capital's 13F filing for Q4 2021, filed 14 Feb 2022.